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Abstract
Background: A core outcome set (COS) can address problems of outcome heterogeneity and outcome reporting
bias in trials and systematic reviews, including Cochrane reviews, helping to reduce waste. One of the aims of the
international Core Outcome Measures in Effectiveness Trials (COMET) Initiative is to link the development and use of
COS with the outcomes specified and reported in Cochrane reviews, including the outcomes listed in the summary
of findings (SoF) tables. As part of this work, an earlier exploratory survey of the outcomes of newly published 2007
and 2011 Cochrane reviews was performed. This survey examined the use of COS, the variety of specified outcomes,
and outcome reporting in Cochrane reviews by Cochrane Review Group (CRG). To examine changes over time and
to explore outcomes that were repeatedly specified over time in Cochrane reviews by CRG, we conducted a follow-up
survey of outcomes in 2013 Cochrane reviews.
Methods: A descriptive survey of outcomes in Cochrane reviews that were first published in 2013. Outcomes
specified in the methods sections and reported in the results section of the Cochrane reviews were examined by
CRG. We also explored the uptake of SoF tables, the number of outcomes included in these, and the quality of
the evidence for the outcomes.
Results: Across the 50 CRGs, 375 Cochrane reviews that included at least one study specified a total of 3142
outcomes. Of these outcomes, 32 % (1008) were not reported in the results section of these reviews. For 23 %
(233) of these non-reported outcomes, we did not find any reason in the text of the review for this non-report.
Fifty-seven percent (216/375) of reviews included a SoF table.
Conclusions: The proportion of specified outcomes that were reported in Cochrane reviews had increased in
2013 (68 %) compared to 2007 (61 %) and 2011 (65 %). Importantly, 2013 Cochrane reviews that did not report
specified outcomes were twice as likely to provide an explanation for why the outcome was not reported. There
has been an increased uptake of SoF tables in Cochrane reviews. Outcomes that were repeatedly specified in
Cochrane reviews by CRG in 2007, 2011, and 2013 may assist COS development.
Keywords: Core outcome set, Systematic review, Outcome reporting bias
Background
The Core Outcome Measures for Effectiveness Trials
(COMET) Initiative, launched in 2010, seeks to advance
the development of core outcome sets (COS) to address
problems of outcome heterogeneity and outcome report-
ing bias [1, 2]. COS are minimum sets of outcomes that
should be measured in any trial for a specific condition
of interest, thus promoting consistency in the availability
of information of the effects of interventions on key out-
comes [3]. The COMET Initiative aims to link the devel-
opment and use of COS with the specification of
outcomes for Cochrane reviews, including the outcomes
listed in their summary of findings (SoF) tables. The
Cochrane Collaboration is a not-for-profit organisation
that produces systematic reviews (Cochrane reviews),
which summarise information from individual studies to
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inform health decisions [4]. Organisationally, it is struc-
tured into Cochrane Review Groups (CRGs) that are
supported by a central administration. CRGs are disease
and health condition-focused groups that work with
Cochrane review authors and editors to develop
Cochrane reviews. Summary of findings tables were de-
veloped by Grading of Recommendations Assessment,
Development and Evaluation (GRADE) and were intro-
duced into Cochrane reviews in 2008. These tables
include a summary of the evidence for important
outcome(s), as selected by the review authors, and
the quality of this evidence [5]. They improve
readers’ understanding and speed of retrieval of the
findings of Cochrane reviews, and thus, inclusion of
the most relevant outcomes in these tables is import-
ant [6, 7]. As COS are key outcomes that should be
measured, they may provide a useful way to select
outcomes to include in SoF tables. In a survey of
CRG co-ordinating editors, 73 % suggested that COS
should be used in SoF tables [8].
As part of our work within the COMET Initiative, we
performed an initial exploratory survey of outcomes in
Cochrane reviews that were published in full for the first
time in 2007 and 2011 [9]. This survey explored the var-
iety of outcomes used in these Cochrane reviews and the
use of COS in reviews on specific conditions. The survey
also identified the proportion of outcomes specified in
the methods section that was reported in the results sec-
tion of the Cochrane reviews and assessed the uptake of
SoF tables in 2011 Cochrane reviews. Outcomes were
examined by CRGs as a meaningful way to explore COS
and outcome reporting in Cochrane reviews. The results
of this initial survey showed that 37 % (1996/5363) of
outcomes specified in the methods section of 702
Cochrane reviews that had studies in them were not re-
ported in the results section of these reviews. For 14 %
(732/5363) of cases, we did not find any reason in the
text of the review for not reporting the outcome(s) in
the review. None of the Cochrane reviews explicitly
referred to a COS when specifying outcomes, and
31 % of 361 newly published 2011 Cochrane reviews
that had studies in them had a SoF table. To deter-
mine possible changes in the use of COS in Cochrane
reviews and changes in outcome reporting over time
and to explore consistency in outcomes specified in
reviews of individual CRGs (defined as being specified
repeatedly by at least half of the new reviews in the
individual CRGs in 2007, 2011, and 2013), we con-
ducted a follow-up survey using Cochrane reviews
published in full for the first time in 2013. As for the
initial survey, this follow-up survey was concerned
with examining what outcomes were examined in
Cochrane reviews, rather than how these outcomes
were measured.
Aim
The aim of this study was to survey the outcomes used
in newly published 2013 Cochrane reviews as a follow-
up to the survey of outcomes in newly published 2007
and 2011 Cochrane reviews [9].
Objectives
1. To identify and highlight the use of COS in reviews
from CRGs
2. To identify the number and variety (i.e. different
types) of outcomes specified and reported in these
Cochrane reviews by CRG
3. To identify the inclusion of SoF tables in these
Cochrane reviews by CRG, including where SoF
tables are being used, to examine the number of
outcomes included in them and the quality of
evidence (GRADE) for these outcomes
4. To compare the findings for objectives 1–3 with the
findings of the initial survey of 2007 and 2011 newly
published reviews
Methods
We conducted a descriptive survey of Cochrane reviews
published in 2013 between March and August 2014.
This follow-up survey was planned at the time of the
initial survey to identify changes over time. The sample
of Cochrane reviews in this repeat survey were thus
published 5 and 2 years following the years of publica-
tion of the Cochrane reviews included in the initial sur-
vey, 3 years after the launch of the COMET Initiative,
and 5 years after the introduction of SoF tables in
Cochrane reviews.
We identified Cochrane reviews published in full for
the first time in 2013 from the Cochrane repository
Archie and retrieved full texts from the Cochrane
Database of Systematic Reviews. Data that were ex-
tracted from each Cochrane review are presented in
Table 1, and we constructed a separate data extraction
table for each CRG. FW conducted the data extraction
using the same template and guidelines that had been
used by the researcher who had conducted data extrac-
tion for the initial survey (VS) [9] to ensure consistency
in how outcomes were counted. Some of these guide-
lines, which are described further below, given the sheer
variety in how outcomes were specified and the diffi-
culty, in some instances, in identifying a clear alignment
of the outcome to a specific category, were challenging
to create. For this reason, in some cases, the ‘rules’
around extracting, counting, and categorising of out-
come types were based on considerable discussion and
consensus. For example, an outcome like ‘hospitalisation
due to adverse effects’ could arguably be aligned to one
of two major categories such as the domains of ‘hospital’
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or ‘adverse events’. To handle these types of outcomes, a
decision was reached, through discussion and consensus,
that the main ‘stem’ of the outcome, that is the first
appearing major domain within the outcome type, would
indicate the alignment of the outcome, in the example’s
case, ‘hospitalisation’. The following guidelines, to ensure
consistency across surveys, were used to handle count-
ing of outcomes in the Cochrane reviews. Specified out-
comes in each review were identified by counting the
number of separately listed outcomes in the methods
section of the review. Where an outcome was divided
further into sub-outcomes, it was still counted as 1 out-
come. For example, if the outcome ‘adverse events’ was
specified, but, the review authors also provided a list of
examples of possible associated adverse events, we re-
ferred to ‘adverse events’ as the main outcome and to
the listed examples of possible adverse events as sub-
outcomes. Only the main outcome was counted in this
case. Similarly, as the survey focused on ‘what’ outcomes
were being measured and not ‘how’ they were measured,
we did not count the different methods of measuring the
same outcome as separate outcomes, rather the main
outcome was counted once only. For example, if the out-
come ‘pain’ was listed in the methods section of a re-
view, and the review authors additionally specified pain
as measured by visual analogue scale or numerical pain
rating scale, we counted the outcome ‘pain’ as one out-
come, based on outcome type, and not as two based on
different measurement methods. The numbers of out-
comes reported in the results section of reviews were
similarly counted.
In the initial survey, 15 outcome categories had
emerged from a scoping overview of the extracted data
across the CRGs. These categories “Rather than attempt-
ing to define outcome domain systems, we used to
extract and manage the data for analyses purposes” ([9],
p. 239). In this sense, these categories are not definitive
domains, nor do we mean them to be; rather, they are
used in this survey to describe the types of categories of
outcomes that are being used in Cochrane reviews and
the variety of the types of individual outcomes that are
reflective of these categories. These categories were: ad-
verse events or effects (AE), mortality/survival, infection,
pain, psychosocial, quality of life, activities of daily living
(ADL), medication, economic, hospital, operative, com-
pliance (with treatment), withdrawal (from treatment/
study), satisfaction (patient/clinician/other healthcare
provider), and other physiological or clinical (other than
adverse events/effects, mortality/survival, pain, and op-
erative outcomes). In this repeat survey, outcomes speci-
fied in the included reviews across all CRGs were
categorised using these same categories so that compari-
sons to the initial survey could be made.
We used descriptive statistics to analyse the data.
Spearman’s correlation was used to assess any link between
the number of outcomes specified in a Cochrane review
and the proportion of outcomes that were reported in the
results section of the review and in the SoF table.
Results
We identified 453 Cochrane reviews published in 2013
from 51 CRGs. After excluding 8 Cochrane reviews of
diagnostic studies, 3 Cochrane overviews of reviews, 1
Cochrane review of qualitative studies, and all (2)
Cochrane reviews by the methodology CRG, we included
439 Cochrane reviews from 50 CRGs in this survey.
None of the Cochrane reviews stated explicitly that they
used a COS in specifying their review outcomes.
Number of specified outcomes in reviews
The number of specified outcomes in each Cochrane
review ranged from 1 (3 reviews) to 62 (1 review), with
a median of 7 outcomes, and an interquartile range of
5–10 outcomes. Of the 3 Cochrane reviews that specified
1 outcome only, 1 review assessed a specific drug adverse
effect [10], 1 review assessed interventions for smoking
cessation [11], and 1 review examined the effectiveness of
a drug for a specific type of poisoning with mortality as its
only outcome [12]. The review that specified 62 outcomes
assessed different types of dietary advice to women with
gestational diabetes and specified short and long-term out-
comes for both mother and child [13].
Next, we compared the distribution of the number of
specified outcomes in Cochrane reviews published
in 2013 with the number of outcomes specified in
Cochrane reviews published in 2007 and 2011 [9] (Fig. 1).
Most Cochrane reviews published in 2007, 2011, and
2013 specified between 6 and 10 outcomes, whereas very
few Cochrane review specified more than 20 outcomes.
Table 1 Data that was extracted from included Cochrane reviews
• The number of included studies in the review
• The outcomes specified in the methods section of the review
• The outcomes reported in the findings section of the review (either
narratively, numerically (e.g. using a risk ratio, odd ratio, risk difference)
or in the meta-analysis)
• Possible reasons for not reporting an outcome in the review, for
example when an outcome specified in the review had not been
examined or reported in the studies included in that review
• Additional outcomes that were reported but that had not been
specified in the methods section
• Inclusion of a SoF table in the review
• The number of outcomes in the SoF table (if applicable)
• The quality of evidence (GRADE) for the outcomes in the SoF table
(if applicable)a
aIf outcomes presented at more than one follow-up time point or for more
than one comparison had different quality grades (which was the case in 24
SoF tables), the lowest quality grade was counted for that outcome
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Reporting of specified outcomes
The 439 included Cochrane reviews specified a total
of 3644 outcomes in their methods sections. After
excluding Cochrane reviews that had no studies in them
(65 reviews), 68 % (2134/3142) of the specified out-
comes were reported in the results section of the
reviews. Of the 1008 non-reported outcomes across all
Cochrane reviews that had studies in them, 77 % (775/
1008) were not reported in the reviews’ results sections
because the outcomes had not been reported in the
studies included in the reviews or the review authors
had not been able to extract the relevant data for that
outcome. However, for the remaining 23 % (233/1008)
of outcomes not reported in the Cochrane reviews, we
did not find a clear reason in the text of the review for
this non-report (Fig. 2). In 12 Cochrane reviews, a total
of 58 outcomes were noted in the review as being added
post-hoc to the protocol. Of these 58 outcomes, 15 had
been added to the list of specified outcomes in the
methods section of these reviews by the authors. The
remaining 43 were only present in the results section of
the review.
There was a weak negative correlation between the
number of outcomes specified and the proportion of the
specified outcomes that were reported (Spearman’s cor-
relation −0.3; p < 0.0001); Cochrane reviews that speci-
fied a larger number of outcomes in their methods
section reported a smaller relative proportion of these
outcomes in the results compared to Cochrane reviews
that specified a smaller number of outcomes in their
methods section. However, there was no correlation
between the number of outcomes specified and the
number of non-reported outcomes that did not have a
clear reason for the non-report (Spearman’s correlation
0.079; p = 0.129).
When we examined primary outcomes only, we found
that 84 % (698/829) of the specified primary outcomes
were reported in the results section of the Cochrane
reviews (range 22 % (1 CRG) to 100 % (16 CRGs) and
median 89 % across CRGs). Eighty-nine percent of the
131 non-reported primary outcomes were not reported
because the included studies did not either measure or
report them. For the remaining 11 % of non-reported
primary outcomes, we did not find any reasons in the
text of the reviews for why these outcomes were not
reported.
Outcome variation/consistency within Cochrane
review groups
There was considerable variation in the outcomes
specified in the Cochrane reviews of the individual
CRGs, particularly in the category ‘other physiological/
clinical’.
Additional file 1 shows the outcomes that were speci-
fied in at least half the 2013 reviews for each CRG and
makes comparison with the 2007 and 2011 Cochrane
reviews [9]. The outcome ‘adverse events’ was specified
in ≥50 % of reviews for 38 of the 50 CRGs, ‘quality of
life’ was specified in ≥50 % of reviews for 17 of the
50 CRGs, and the outcome ‘mortality’ was specified
in ≥50 % of reviews for 16 of the 50 CRGs. These were
the 3 most commonly specified outcomes. Excluding
CRGs with 2 or fewer new reviews in 2013 (because all
specified outcomes are by default present in ≥50 % of
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Fig. 1 Number of specified outcomes (proportions) in 2007, 2011, and 2013 Cochrane reviews
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reviews), the outcome ‘adverse events’ was specified
in ≥50 % of reviews for 33 of 42 CRGs, the outcome
‘mortality’ was specified in ≥50 % of reviews for 15 of 42
CRGs, and ‘quality of life’ was specified in ≥50 % of
reviews for 13 of 42 CRGs.
Summary of findings tables
Fifty-seven percent (216/375) of the Cochrane reviews
that had studies included in them had a SoF table. Three
Cochrane reviews that did not have any included studies
also provided an empty SoF table, but these were
excluded from the analysis. Of the 216 Cochrane reviews
with a SoF table, 12.5 % (27/216) included 1 outcome in
the table, 16.2 % (35/216) included 2 outcomes, 14.4 %
(31/216) included 3 outcomes, 12.5 % (27/216) included
4 outcomes, 17.1 % (37/216) included 5 outcomes,
11.6 % (25/216) included 6 outcomes, and 14.8 %
(32/216) included 7 outcomes. In addition, 1 Cochrane
review had 8 outcomes and a second had 9 outcomes in
their SoF tables. The number of outcomes in the SoF
table was positively correlated with the number of out-
comes specified in the methods section of the review
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(Spearman’s correlation 0.468, p < 0.0001). Sixty-nine of
the 216 Cochrane reviews with a SoF table included sub-
outcomes for at least 1 outcome in the SoF table. Fur-
thermore, in 8 reviews, the SoF table listed outcomes for
more than 1 follow-up period, and 8 reviews included
outcomes for more than 1 intervention comparison. One
review also presented outcomes for 2 different popula-
tions within the SoF table, and another review listed the
outcomes separately according to the design of the
studies.
The quality of evidence (GRADE) for the results
for the outcomes listed in the SoF tables varied with
a ‘low quality’ grade being the most common grade
(30 %; 266/877 outcomes in all SoF tables). Twenty-
one percent (181/877) of effect size estimates in SoF
tables were based on ‘very low quality’ evidence, 20 %
(178/877) on ‘moderate quality’ evidence, and 8 % (73/877)
had a ‘high quality’ grade. For the remaining outcomes
listed in the SoF tables (179/877), the outcomes had
not been either measured or reported in the included
studies (118/877), insufficient data were present to
estimate an effect size (22/877), or there was no reason
provided for not reporting a quality grade (29/877). One
Cochrane review used a different evidence quality grading
system (strong/moderate/limited/conflicting/inconclusive/
no evidence).
The proportion of Cochrane reviews with SoF tables
within individual CRGs ranged from 0 % (3 CRGs) to
100 % (12 CRGs) with a median of 50 % (Fig. 3).
Discussion
In this follow-up survey of outcomes in Cochrane re-
views, we found that the numbers of specified outcomes
in the reviews were proportionately similar for 2007,
2011, and 2013 newly published Cochrane reviews, and
the median number of outcomes specified in the
methods section of the reviews was 7 for all years [9].
However, the maximum number of outcomes was only
26 in 2007 and 2011, whereas 7 Cochrane reviews
from 2013 specified a greater number of outcomes. Al-
though larger numbers of specified outcomes were not
related to non-reporting in the absence of a clear rea-
son being given for this non-report, the selection of
outcomes for Cochrane reviews should receive careful
consideration [9].
In this follow-up survey, 68 % of all specified out-
comes were reported in the results section of the
Cochrane reviews. This is an increase when compared to
the 63 % of specified outcomes that were reported in
2007 and 2011 Cochrane reviews [9]. Moreover, 7 % of
all specified outcomes were not reported, and we did
not find any reason for this non-report in the text
of these Cochrane reviews in 2013. This compares
favourably to the earlier survey that found that 14 % of
specified outcomes were not reported without reasons
given for this non-report in the text of these Cochrane
reviews [9]. Outcome reporting bias, that is, the selec-
tion of reported outcomes based on the outcome results,
may significantly impact on the findings of studies and
Cochrane reviews [1]. This observed reduction (50 %)
over time in non-reporting of outcomes with no reason
provided is welcome. Specified primary outcomes were
also more frequently reported in 2013 than in the earlier
survey, which is reassuring. However, in this survey, we
compared the outcomes reported in the methods section
of the Cochrane reviews with the outcomes reported in
the results section. Ideally, the outcomes specified in the
protocols would be compared with the outcomes re-
ported in the results section of the completed Cochrane
reviews; however, this was beyond the scope of the sur-
vey and is recognised, by the authors, as a limitation.
Outcome variation/consistency within Cochrane
review groups
Considering the findings for the specified outcomes
within each CRG (Additional file 1), 48 of the 50 CRGs
had at least 1 outcome that was specified in more than
half of its reviews. This could be seen as an increase in
consistency in the specified outcomes within CRGs (i.e.
outcomes that are specified repeatedly in at least half of
the reviews of an individual CRG) compared to 2007
and 2011, when only 41 of 50 CRGs had at least 1 out-
come specified in more than half of its reviews. How-
ever, caution should be taken when considering this
finding as 7 CRGs published 2 or fewer new reviews in
2013, meaning that all specified outcomes for these
CRGs must have been specified in at least half of their
reviews.
The slight increase in CRGs that specified the out-
come ‘adverse event/effects’ in at least half of the reviews
from 71 % of CRGs in 2007 and 2011 to 76 % CRGs in
2013 is welcome. However, this is not yet in line with
the Cochrane Handbook for Systematic Reviews of
Interventions’ recommendation that all Cochrane reviews
should try to include adverse effects of interventions [5].
Comparing the outcomes for each CRG that were spe-
cified in at least half of the CRGs’ reviews in 2013 to
those published in 2007 and 2011 [9] in greater detail
(Additional file 1), consistency (defined as specified re-
peatedly in the methods section of at least half of the
reviews in the CRG) across time varied from 1 CRG hav-
ing no single outcome present in at least 50 % of reviews
in 2007, 2011 and 2013, to 2 CRGs that had identical
outcomes present in at least 50 % of reviews for the re-
views published in 2007, 2011, and 2013. The outcomes
that appear to have been consistently specified in
Cochrane reviews over the last six years could possibly
be considered for inclusion in a preliminary COS.
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However, the variation in the outcomes used in the re-
views of a CRG will depend on the scope of the individ-
ual CRG. Logically, CRGs with a broader scope of
reviews, covering multiple areas of health care, are likely
to have a wider variety of outcomes.
Summary of findings tables
The guidance in the Cochrane Handbook for Systematic
Reviews of Interventions strongly recommends that
Cochrane reviews should present the most important
outcomes in a SoF table [5]. There has been an in-
creased uptake of SoF tables in Cochrane reviews over
time, with 57 % of the 2013 Cochrane reviews including
a SoF table, compared to 31 % in 2011 [9]. However, the
uptake of SoF tables varies greatly across CRGs. This rise
may be due to more CRG editors requesting it, as well
as increased training amongst editorial staff and authors
in producing SoF tables. For example, three Cochrane
reviews that had no studies in them still included a SoF
table. The corresponding CRGs appear to request a SoF
table, as standard, for every review as all of their 2013
published reviews had a SoF table. With 73 % of sur-
veyed CRG editors suggesting that COS should be used
in a SoF table [8], the increasing trend of including a
SoF table in Cochrane reviews could be an opportunity
to promote the use of COS in Cochrane reviews. An
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%100%
Dementia & Cognitive Improvement (n=2)
Ear, Nose and Throat Disorders (n=2)
Fertility Regulation (n=2)
Bone Joint Muscle Trauma (n=9)
Pregnancy and childbirth (n=27)
Eyes and vision (n=6)
Childhood cancer (n=4)
Pain, palliative and supportive care (n=22)
Peripheral vascular disease (n=7)
Stroke (n=14)
Breast cancer (n=13)
Cystic Fibrosis & Genetic disorders (n=9)
Drugs and Alcohol (n=6)
Hepato-Biliary (n=9)
Incontinence (n=3)
MS & Rare diseases of CNS (n=3)
Neonatal (n=3)
Renal (n=8)
Gynaecological cancer (n=11)
Heart (n=17)
Back (n=2)
Consumer & Communication (n=6)
HIV/AIDS (n=10)
Injuries (n=8)
Lung cancer (n=2)
Skin (n=6)
Neuromuscular disease (n=5)
Acute Respiratory (n=6)
Occupational health and safety (n=3)
Wounds (n=16)
Depression, Anxiety and Neurosis (n=8)
Epilepsy (n=4)
Infectious Diseases (n=9)
Public health (n=5)
Menstrual disorders and subfertility (n=13)
Development, psychosocial and learning problems (n=7)
Metabolic and endocrine disorders (n=7)
Anaesthesia (n=16)
Colorectal cancer (n=3)
Effective Practice and organisations of care (n=7)
Haematological Malignancies (n=6)
Hypertension (n=2)
IBD and functional bowel disorders (n=2)
Musculoskeletal (n=11)
Oral health (n=9)
Prostatic and urological cancers (n=2)
Tobacco addiction (n=1)
Airways (n=18)
Schizophrenia (n=7)
Upper Gastrointestinal and Pancreatic diseases (n=7)
Fig. 3 Proportion of reviews with a summary of findings table by Cochrane Review Group
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examination of the Cochrane reviews for our survey,
however, found that as yet, none of the included
Cochrane reviews stated specifically that they were using a
COS to guide the selection of their outcomes or their deci-
sions on which outcomes to present in the SoF table.
In line with the recommendation of identifying a max-
imum of up to 7 outcomes for including in a SoF table
[5], all but 2 reviews had 7 or fewer outcomes in their
SoF table. Four reviews did not have a grade of the qual-
ity of the evidence for the outcomes in their SoF table,
despite this being part of the standard content [5].
Conclusions
The proportion of specified outcomes that were reported
in Cochrane reviews that had studies in them increased
over time, from 61 % in 2007 to 65 % in 2011 and 68 %
in 2013. Importantly, 2013 Cochrane reviews that did
not report specified outcomes were twice as likely to
provide an explanation for this non-report (i.e. 14 % in
the 2007 and 2011 Cochrane reviews combined, com-
pared to 7 % in the 2013 Cochrane reviews). Ideally, to
reduce the potential for selection and reporting biases, a
legitimate reason should be given for why all non-
reported specified outcomes in Cochrane reviews are
not being reported.
None of the Cochrane reviews stated explicitly that
they used a COS in deciding which outcomes to specify
in the methods sections of their reviews or to include in
their SoF tables, although they may have considered a
COS without clearly saying that specified outcomes
came from it. Data on outcomes that are repeatedly be-
ing specified in the Cochrane reviews of a CRG at the 3
time points of the initial survey and this repeat survey
(2007, 2011, 2013) may be useful for COS developers
when considering what outcomes to include in a prelim-
inary set of outcomes for a COS. It can provide another
source of information in addition to the involvement of
key stakeholders in COS development [2].
There has been an increased inclusion of SoF tables in
Cochrane reviews, but these were still absent from
nearly half of 2013 Cochrane reviews. As the use of SoF
tables continues to be promoted, development of COS
could go hand in hand with an increasing use of SoF ta-
bles in Cochrane reviews.
Additional file
Additional file 1: Consistency of outcomes specified in 2013
Cochrane Reviews compared to 2007 and 2011 Cochrane Reviews.
Outcomes that were specified in at least half of the reviews first
published in 2013 are presented by CRG.
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